High CV risk in young people is a 'delayed' crisis

Published Date: 08 Mar 2023

Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.

Read Full News

Latest News

Lower Right Heart Reserve Linked to Worse Shunt Outcomes

In patients with heart failure, a lower TAPSE/PASP ratio is linked to higher rates of cardiovascular death or heart failure hospitalisation after interatrial shunting.

Dapagliflozin Cuts Heart Risk in T2D With Advanced Fibrosis

Dapagliflozin can reduce the risk for major adverse cardiovascular events in patients with T2D at a high risk for advanced liver fibrosis, according to a retrospective study.

CMS Proposes TAVR Coverage Framework

Treating patients with symptomatic aortic stenosis does not require collecting further evidence.

Stopping Aspirin Early May Cut Bleeding Risk After Stents

Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.

Obesity Drives 1 in 7 Polypharmacy Cases in Older US Adults

A US cohort study finds that BMI-defined obesity accounts for approximately 15% of polypharmacy cases among older adults, representing an estimated 3.3 million cases.

Why Men Account for Most Drowning Deaths

Drowning deaths are much more common among men, with overconfidence, alcohol, and open-water exposure emerging as key risk factors.

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Latest News

In patients with heart failure, a lower TAPSE/PASP ratio is linked to higher rates of cardiovascular death or heart failure hospitalisation after interatrial shunting.

Dapagliflozin can reduce the risk for major adverse cardiovascular events in patients with T2D at a high risk for advanced liver fibrosis, according to a retrospective study.

Treating patients with symptomatic aortic stenosis does not require collecting further evidence.

Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.

A US cohort study finds that BMI-defined obesity accounts for approximately 15% of polypharmacy cases among older adults, representing an estimated 3.3 million cases.

Drowning deaths are much more common among men, with overconfidence, alcohol, and open-water exposure emerging as key risk factors.

News All Time

Less Than 1% of Hypertension Cases Screened for Primary Aldosteronism

Real-world study turned up a "meaningful" 8.7% positive rate

FDA Clears First OTC Continuous Glucose Monitor for Kids

Authorization of Stelo integrated CGM extends to children without diabetes as well

Teplizumab Approval Expands to Early Type 1 Diabetes

Product aims to disrupt the autoimmune attack against insulin-producing beta cells

COVID Shots Tied to Lower Risks of Heart Attack, Cardiac Death

Three studies suggest that getting a COVID vaccine is still beneficial for adults

Diabetes Patients on Semaglutide Had Fewer Fractures, Study Finds

"It would be exciting if these medications were truly bone protective," says researcher

Study Looks at Risk for Dementia After Shingles Vaccine in High-Risk Group

Analysis assessed 500,000 skilled-nursing facility residents in the U.S.

Balloon-Expandable TAVR Has Struggles Evident at 10-Year Follow-Up

Mortality linked to second-generation Sapien XT in intermediate surgical risk cohort

PAs in Cardiology; Increased Risks With Gout; Bad News for Female Heart Recipients

Recent developments of interest in cardiovascular medicine

Lifestyle Change in Prediabetes Cuts Risk of Multimorbidity

Landmark trial followed participants for 21 years

Brain Health Signals Emerge in How Patients Speak

Doctor-patient conversations may hold clues to cognitive impairment

Study on Weekly Resistance Training Finds Sweet Spot for Heart Protection

Cohort study supports consistent muscle-building exercise, even in older women

This Test Outperformed SCORE2 for Gauging Heart Risk in Rheumatic Disease

Quick, ultrasound-based assessment could readily be used in routine practice

A Way to Successfully Rein in Unnecessary Blood Thinner Use

Health system tests multilevel approach for reducing high-risk antiplatelet prescribing

Food Labels and Childhood Obesity; Prehabilitation in Older Adults

Also in TTHealthWatch: socioeconomic status and brain development in kids

Hypertension Drug Recall; Hantavirus Quarantine Ends; Bending Over and Miscarriage

Health news and commentary gathered by MedPage Today staff

'Super Movers' Show Signs of Exceptional Brain Aging

Fast walkers in their 80s had less risk of cognitive decline, study suggests

Recommended News For You

Kidney cancer: Understanding what a renal cell carcinoma diagnosis means

Bayer is transforming pharmaceutical research into women's health

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

Guideline on management of early-stage non-small cell lung cancer released

CAR-T Warning for Secondary Malignancies: Warranted or Not?

AI tool identifies women at high risk of interval breast cancer

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

Recommended Articles For You

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium 

An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025 

Exploring the Latest Advances in PTLD Cancer Treatment 

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Watch for Psoriasis After Cancer Immunotherapy, Study Says

2.

AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence

3.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

4.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

5.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

1.

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms

2.

Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities

3.

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine

4.

Glycopyrrolate: The Secret Weapon for Excessive Sweating 

5.

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

2.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

3.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

4.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot